{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:17:20Z","timestamp":1789885040046,"version":"4.0.1"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2017M622145"],"award-info":[{"award-number":["2017M622145"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2017M612217"],"award-info":[{"award-number":["2017M612217"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011324","name":"Source Innovation Planning of Qingdao","doi-asserted-by":"publisher","award":["17-1-1-42-jch"],"award-info":[{"award-number":["17-1-1-42-jch"]}],"id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011324","name":"Source Innovation Planning of Qingdao","doi-asserted-by":"publisher","award":["17-1-1-45-jch"],"award-info":[{"award-number":["17-1-1-45-jch"]}],"id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":[".2015JM8396"],"award-info":[{"award-number":[".2015JM8396"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2016JQ8028"],"award-info":[{"award-number":["2016JQ8028"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81272957"],"award-info":[{"award-number":["81272957"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81472520"],"award-info":[{"award-number":["81472520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81502354"],"award-info":[{"award-number":["81502354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2019,5,31]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The Oral Squamous Cell Carcinoma (OSCC) is one of the most frequent cancer types. Failure of treatment of OSCC is potentially lethal because of local recurrence, regional lymph node metastasis, and distant metastasis. Chemotherapy plays a vital role through suppression of tumorigenesis. Cyclosporine A (CsA), an immunosuppressant drug, has been efficiently used in allograft organ transplant recipients to prevent rejection, and also has been used in a subset of patients with autoimmunity related disorders. The present study aims to investigate novel and effective chemotherapeutic drugs to overcome drug-resistance in the treatment of OSCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Cells were incubated in the standard way. Cell viability was assayed using the MTT assay. Cell proliferation was determined using colony formation assay. The cell cycle assay was performed using flow cytometry. Apoptosis was assessed using fluorescence-activated cell sorting after stained by the Annexin V-fluorescein isothiocyanate (FITC). Cell migration and invasion were analyzed using wound healing assay and tranwell. The effect of COX-2, c-Myc, MMP-9, MMP-2, and NFATc1 protein expression was determined using Western blot analysis while NFATc1 mRNA expression was determined by RT-PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>In vitro studies indicated that CsA inhibited partial OSCC growth by inducing cell cycle arrest, apoptosis, and the migration and invasion of OSCC cells. We also demonstrated that CsA could inhibit the expression of NFATc1 and its downstream genes COX-2, c-Myc, MMP-9, and MMP-2 in OSCC cells. Furthermore, we analyzed the expression of NFATc1 in head and neck cancer through the Oncomine database. The data was consistent with the experimental findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The present study initially demonstrated that CsA could inhibit the progression of OSCC cells and can mediate the signal molecules of NFATc1 signaling pathway, which has strong relationship with cancer development. That explains us CsA has potential to explore the possibilities as a novel chemotherapeutic drug for the treatment of OSCC.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871520618666181029170605","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T11:58:46Z","timestamp":1540987126000},"page":"248-255","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro"],"prefix":"10.2174","volume":"19","author":[{"given":"Ling","family":"Gao","sequence":"first","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Shangluo Central Hospital, Shangluo, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxian","family":"Le","sequence":"additional","affiliation":[{"name":"Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Ren","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Li","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Song","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibo","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Dou","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Y.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqian","family":"Zhi","sequence":"additional","affiliation":[{"name":"Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2007.00579.x","volume":"37","author":"Napier S.S.","year":"2008","unstructured":"Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: An overview of the literature.","journal-title":"J Oral Pathol Med"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2334\/josnusd.52.267","volume":"52","author":"Marocchio L.S.","year":"2010","unstructured":"Marocchio LS, Lima J, Sperandio FF, Corr\u00eaa L, de Sousa SOM. Oral squamous cell carcinoma: An analysis of 1,564 cases showing advances in early detection.","journal-title":"J Oral Sci"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tripleo.2005.07.038","volume":"102","author":"Massano J.","year":"2006","unstructured":"Massano J, Regateiro FS, Janu\u00e1rio G, Ferreira A. Oral squamous cell carcinoma: Review of prognostic and predictive factors.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics.","journal-title":"Cancer J Clin"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jcb.25255","volume":"117","author":"Sambandam Y.","year":"2016","unstructured":"Sambandam Y, Sakamuri S, Balasubramanian S, Haque A. rank ligand modulation of autophagy in oral squamous cell carcinoma tumor cells.","journal-title":"J Cell Biochem"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","volume":"97","author":"Pisani B.","year":"2002","unstructured":"Pisani B, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population.","journal-title":"Int J Cancer"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s10147-011-0358-4","volume":"18","author":"Kiyosue T.","year":"2013","unstructured":"Kiyosue T, Kawano S, Matsubara R, Goto Y, Hirano M, Jinno T, Toyoshima T, Kitamura R, Oobu K, Nakamura S. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma International.","journal-title":"Int J Clin Oncol"},{"key":"ref=8","first-page":"558","author":"Watts R.","year":"2009","unstructured":"Watts R, Clunie G, Hall F, Marshall T.","journal-title":"Rheumatology"},{"key":"ref=9","unstructured":""},{"key":"ref=10","unstructured":""},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"Liu J.","year":"1991","unstructured":"Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin\u2013cyclosporin A and FKBP\u2013FK506 complexes.","journal-title":"Cell"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.bbamcr.2014.06.020","volume":"1843","author":"Ram B.M.","year":"2014","unstructured":"Ram BM, Ramakrishna G. Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition.","journal-title":"Biochim Biophys Acta"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2016.06.002","volume":"379","author":"Shou J.","year":"2016","unstructured":"Shou J, You L, Yao J, Xie J, Jing J, Jing Z, Jiang L, Sui X, Pan H, Han W. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.","journal-title":"Cancer Lett"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuint.2005.05.010","volume":"47","author":"Zupanska A.","year":"2005","unstructured":"Zupanska A, Dziembowska M, Ellert-Miklaszewska A, Gaweda-Walerych K, Kaminska B. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.","journal-title":"Neurochem Int"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3892\/ijmm.2012.989","volume":"30","author":"Jiang K.","year":"2012","unstructured":"Jiang K, He B, Lai L, Chen Q, Liu Y, Guo Q, Wang Q. Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.","journal-title":"Int J Mol Med"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"557S","DOI":"10.1016\/j.transproceed.2003.12.046","volume":"36","author":"Ponticelli C.","year":"2004","unstructured":"Ponticelli C, Tarantino A, Campise M, Montagnino G, Aroldi A, Passerini P. From cyclosporine to the future.","journal-title":"Transplant Proc"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/352803a0","volume":"352","author":"Flanagan W.M.","year":"1991","unstructured":"Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.","journal-title":"Nature"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","volume":"109","author":"Crabtree G.R.","year":"2002","unstructured":"Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells.","journal-title":"Cell"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1101\/gad.1102703","volume":"17","author":"Hogan P.G.","year":"2003","unstructured":"Hogan PG, Chen L, Nardone J, Rao A. Transcription regulation by calcium, calcineurin, and NFAT.","journal-title":"Genes Dev"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"Greenhough A.","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.","journal-title":"Carcinogenesis"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1038\/sj.emboj.7601246","volume":"25","author":"Buchholz M.","year":"2006","unstructured":"Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+\/calcineurin signaling pathway.","journal-title":"EMBO J"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.18632\/oncotarget.2750","volume":"6","author":"Kawahara T.","year":"2015","unstructured":"Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.","journal-title":"Oncotarget"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s000180050495","volume":"57","author":"Johansson N.","year":"2000","unstructured":"Johansson N, Ahonen M, K\u00e4h\u00e4ri VM. Matrix metalloproteinases in tumor invasion.","journal-title":"Cell Mol Life Sci"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.stem.2010.11.027","volume":"8","author":"Li X.","year":"2011","unstructured":"Li X, Zhu L, Yang A, Lin J, Tang F, Jin S, Wei Z, Li J, Jin Y. Calcineurin-NFAT signaling critically regulates early lineage specification in mouse embryonic stem cells and embryos.","journal-title":"Cell Stem Cell"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000097608","volume":"18","author":"Sachinidis A.","year":"2006","unstructured":"Sachinidis A, Schwengberg S, Hippler-Altenburg R, Mariappan D, Kamisetti N, Seelig B, Berkessel A, Hescheler J. Identification of small signalling molecules promoting cardiacspecific differentiation of mouse embryonic stem cells.","journal-title":"Cell Physiol Biochem"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2016.06.002","volume":"379","author":"Shou J.","year":"2016","unstructured":"Shou J, You L, Yao J, Xie J, Jing J, Jing Z, Jiang L, Sui X, Pan H, Han W. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.","journal-title":"Cancer Lett"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/mc.22265","volume":"55","author":"Kawahara T.","year":"2016","unstructured":"Kawahara T, Kashiwagi E, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.","journal-title":"Mol Carcinog"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1007\/s10620-012-2255-8","volume":"57","author":"Wang S.","year":"2012","unstructured":"Wang S, Kang X, Cao S, Cheng H, Wang D, Geng J. Calcineurin\/NFATc1 pathway contributes to cell proliferationin hepatocellular carcinoma.","journal-title":"Dig Dis Sci"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pros.22937","volume":"75","author":"Kawahara T.","year":"2014","unstructured":"Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Ishiguro H, Miyamoto H. The role of NFATc1 inprostate cancer progression: Cyclosporine A and tacrolimusinhibit cell proliferation, migration, and invasion.","journal-title":"Prostate"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1182\/blood-2009-12-257378","volume":"116","author":"Pham L.V.","year":"2010","unstructured":"Pham LV, Tamayo AT, Li C, Bueso-Ramos C, Ford RJ. An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.","journal-title":"Blood"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T11:22:38Z","timestamp":1605352958000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166751\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520618666181029170605","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}